CAJ | 학술논문

目的探讨妊娠并尖锐湿疣( condyloma cuminatum, CA)对妊娠结局的影响及有效的治疗方法。方法选择妊娠期CA终止妊娠63例(终止妊娠组)、妊娠期CA继续妊娠65例(继续妊娠组)及非妊娠期CA 50例(对照组),均采用电离子术治疗,比较3组术后7 d治愈率、术后3个月复发率,并统计继续妊娠组的妊娠结局。结果终止妊娠组、继续妊娠组、对照组术后7 d治愈率分别为87.30%、86.15%、88.00%,差异无统计学意义(P>0.05)；术后3个月复发率分别为15.87%、36.92%、14.00%,继续妊娠组明显高于其他两组(P<0.05)；3组总治愈率均为100%。继续妊娠组均选择剖宫产结束分娩,新生儿均足月存活,无胎儿宫内发育迟缓、新生儿喉乳头状瘤、生殖器疣及肛门疣等发生。结论妊娠并CA可以继续妊娠,电离子手术治疗妊娠期CA安全、可靠,患者妊娠结局良好。
목적탐토임신병첨예습우( condyloma cuminatum, CA)대임신결국적영향급유효적치료방법。방법선택임신기CA종지임신63례(종지임신조)、임신기CA계속임신65례(계속임신조)급비임신기CA 50례(대조조),균채용전리자술치료,비교3조술후7 d치유솔、술후3개월복발솔,병통계계속임신조적임신결국。결과종지임신조、계속임신조、대조조술후7 d치유솔분별위87.30%、86.15%、88.00%,차이무통계학의의(P>0.05)；술후3개월복발솔분별위15.87%、36.92%、14.00%,계속임신조명현고우기타량조(P<0.05)；3조총치유솔균위100%。계속임신조균선택부궁산결속분면,신생인균족월존활,무태인궁내발육지완、신생인후유두상류、생식기우급항문우등발생。결론임신병CA가이계속임신,전리자수술치료임신기CA안전、가고,환자임신결국량호。
Objective To explore the influence of condyloma acuminatum ( CA) on pregnancy outcome and the effec-tive method for clinical treatment. Methods The electrocautery therapy was performed for 63 pregnant women with CA who ter-minated pregnancy (group A), 65 pregnant women with CA continued pregnancy (group B) and 50 non pregnant women with CA ( control group) . The recovery rate 7 d after the operation and recurrence rate 3 months after the operation were compared in the three groups, and pregnancy outcomes in group B were analyzed. Results The recovery rate 7 d after the operation in group A, B and control group were 87. 30%, 86. 15% and 88. 00% respectively, and there were no statistically significances ( P>0.05);the recurrence rate 3 months after the operation were 15. 87%, 36. 92% and 14. 00% respectively, and the recurrence rate in group B was significantly higher than those in the other two groups (P<0.05);the total recovery rates in the three groups were all 100%. Patients in group B all underwent cesarean, all full-term newborns were live births, and there were no intrauterine growth retardation, newborn laryngeal papilloma, genital warts and anal warts. Conclusion Pregnant women with CA can continue preg-nancy, and electrocautery in treatment of CA during gestation period is safe and reliable with good pregnancy outcomes.